0YUR4KZ
Supplement 2nd Toe, Right to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | Y Anatomical Regions, Lower Extremities |
| Operation | U Supplement |
| Body Part | R 2nd Toe, Right |
| Approach | 4 Percutaneous Endoscopic |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures in this family involve placing biological or synthetic material into or onto a lower extremity anatomical region to physically reinforce or add bulk to existing tissue, rather than to replace missing structure. Surgical mesh used to reinforce weakened fascia or a defect in the leg or foot region, or an autologous or donor graft layered onto tissue to strengthen it, are typical examples.
This type of procedure is chosen when the body part is present and largely intact but needs additional support to hold its shape, resist strain, or heal properly, such as reinforcing a soft-tissue closure after trauma or a prior surgical repair. It differs from simply closing or repairing a wound because material is deliberately added to bolster the area beyond what the patient's own tissue can currently provide.
Anatomy & Axis Detail
2nd Toe, Right
Supplement of the right second toe involves adding graft or synthetic material to reinforce this digit's existing structure, most often its skin envelope, joint capsule, or underlying phalangeal bone. The second toe is frequently affected by hammertoe deformity, and reconstructive work here may include capsular reinforcement after correction or soft tissue augmentation where chronic pressure from an adjacent hallux valgus deformity has caused tissue thinning. Because the second toe sits between the first and third digits, procedures on it are also documented in relation to interdigital contact points and any overlapping or underlapping deformity. The operative report should clarify whether the material placed is the patient's own tissue, donor or animal-derived material, or a synthetic substitute, and which anatomic layer was reinforced, since these details determine the applicable body part and qualifier values for accurate code assignment.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
A coder assigns Supplement when documentation shows material was added to reinforce or augment a body part that remains present, with the graft or mesh serving a support function rather than substituting for an absent structure. The note should specify the material used, whether autograft, allograft, or synthetic mesh, since device and substance qualifiers affect code selection. A common error is coding Supplement when the material is actually replacing a resected or absent structure, which belongs to Replacement instead, or coding Repair when reinforcing material was in fact placed, which should be captured as Supplement.